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Chemical tools to modulate ice formation/growth have great (bio)-
technological value, with ice binding/antifreeze proteins being
exciting targets for biomimetic materials. Here we introduce polymer
nanomaterials that are potent inhibitors of ice recrystallisation using
polymerisation-induced self-assembly (PISA), employing a poly(vinyl
alcohol) graft macromolecular chain transfer agent (macro-CTA).
Crucially, engineering the core-forming blockwith diacetone acrylamide
enabled PISA to be conducted in saline, whereas poly(2-hydroxypropyl
methacrylate) cores led to coagulation. The most active particles
inhibited ice growth as low as 0.5 mg mL1, and were more active
than the PVA stabiliser block alone, showing that the dense packing
of this nanoparticle format enhanced activity. This provides a unique
route towards colloids capable of modulating ice growth.
Ice formation and growth presents major challenges in the main-
tenance of infrastructure,1 adversely affects food texture2 and is a
key consideration in the storage and transport of cells3–6 or
vaccines.7 Extremophile organisms, which live in the coldest
habitats make use of anti-freeze/ice-binding proteins8,9 (AFP/IBPs),
ice-adhesion proteins10 as well as ice-nucleating proteins.11 It has
emerged that it is possible to reproduce the desirable properties of
these diverse proteins using materials science, including polymers
(especially poly(vinyl alcohol), PVA)12–15 self-assembled small
molecules,16 graphenics17,18 and minerals.19 One particularly
desirable property is ice recrystallisation inhibition (IRI); the
prevention of ice crystals from growing (distinct from nucleation).
IRI-activematerials have been found to improve post-thaw recovery
of cryopreserved cells,17,20,21 proteins22 and bacteria.23 It is still not
possible to rationally design new IRIs, and in particular generating
IRI-active polymer colloids/nanomaterials is challenging. Immo-
bilisation of PVA onto gold particles by ‘grafting to’ retains, but does
not enhance, activity24 as do coacervates.25 Similarly, assembly of
Type III AFPs into dendrimers26 or on gold particles27 allows
binding of multiple ice faces, but affords no overall increase in
activity. This is surprising as AFP/IBPs typically show more activity
as molecular weight or aggregation increases28,29 and theory pre-
dicts that the rate of ice nucleation requires large protein aggregates
to function.30 Graphene oxide nanosheets also show strong particle
size effects on ice formation.31 How large particles can bind and
inhibit ice is not clear and if the design rules are related to that of
protein/polymers is unknown. There is a clear opportunity to
develop nanomaterials containing ice bindingmacromolecules with
controlled presentation and architecture.
Polymerisation-induced self-assembly (PISA) has emerged as
a powerful tool to generate multivalent polymeric nanomaterials
of controlled morphology and size at high solid contents.32 The
versatility of this method has allowed the synthesis of nano-
objects for drug delivery,33,34 cell storage,35,36 permeable nano-
reactors,37,38 and has been extensively reviewed.39–42 A challenge with
many PISA formulations is the need to conduct PISA in biological
media, which invariably contain salts. Armes and co-workers
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In this manuscript, the concept of using polymerisation-induced self-
assembly (PISA) to generate unique nanomaterials that are capable of
inhibiting ice growth is shown for the first time. Ice growth is a major
problem in cell storage, infrastructure maintenance and in the food industry.
Existing solutions to control ice growth have focussed on using antifreeze/ice-
binding proteins from extremophile organisms and more recently polymeric
inhibitors have emerged. Previous reports of nanomaterial architectures
containing ice recrystallisation active macromolecules did not show
enhancements in activity. In contrast native antifreeze/ice-binding proteins
show size and aggregation state dependent activity, which we have
successfully mimicked here. Crucially to achieve this, we tuned the PISA
process to allow it to be conducted in saline solution by careful selection of
the core-forming block enabling us to use our desired (and indeed essential)
coronal macroinitiator. Secondly, due to the dense surface grafting of the
coronal block, the resulting particles are extremely potent IRIs functioning
below 1 mg mL1. This new ice growth controlling particle formulation
opens the door to advanced colloidal dispersions capable of withstanding
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engineered stable nanoparticles by changing the steric stabilizer
block to poly(sulfobetaines), to enhance solubility in the presence
of salt.43 Cationic diblock spherical copolymer nanoparticles have
also shown surprisingly strong aggregation resistance in electrolyte
solutions.44 However, if PISA is to be used to design nanoparticles
to interface and modulate the growth of ice, the corona-forming
block is limited to polymers which can bind ice (e.g. PVA).
Taking into account the above, we here address the challenges of
(i) conducting PISA in saline without restricting the corona-forming
block, and (ii) introducing ice recrystallisation inhibition activity
into polymer particles. This is achieved using diacetone acrylamide,
rather than the common 2-hydroxypropyl methacrylate core-
forming monomer, with a poly(vinyl alcohol) based macro-
graft-RAFT agent. The resulting particles are potent IRI agents
and present a unique approach to employ self-assembled colloidal
dispersions for IRI.
Poly(vinyl alcohol) was selected as the corona-forming block,
as it is the most active polymeric IRI agent known.45 Commercially
available PVA (10 kDa/DP = 181) was selected which was grafted
with 4-cyano-4-[(ethylsulfanylthiocarbonyl)sulfanyl]pentanoic acid
CTA (CEPA), by DCC coupling to afford a water soluble PVA-based
graft macro-CTA. The macro-CTA was thoroughly dialysed to
remove unfunctionalised RAFT agent. Due to overlapping signals,
quantification of the grafting density by 1H NMR spectroscopy was
not possible. Thermogravimetric analysis (TGA) showed that a
ratio of four CEPA molecules per a hundred hydroxyl groups were
present, meaning that approximately seven CTA groups were
grafted per PVA chain (ESI†). SEC analysis of PVA181 graft macro-
CTA revealed a small increase in molecular weight compared to
PVA181 (ESI†).
The most widely used core-forming monomer for PISA,
2-hydroxypropyl methacrylate (HPMA), was used for thermally-
initiated dispersion polymerisations at 60 1C (10% w/w) in
water, and later in 0.01 M saline. NaCl is essential for IRI activity
testing and lack of saline dispersibility would prevent assessment
of activity.46 In water, monomer conversions above 95% (as
confirmed by 1H NMR analysis) and stable PISA dispersions were
obtained when targeting PHPMA degrees of polymerisation of
50–300. Dynamic light scattering revealed nanoparticles ranging
in diameter from 200–400 nm as a function of PHPMA chain
length. Dry-state TEM (Fig. 1C) revealed the formation of only
spherical morphologies (see ESI† for all characterisation) and
this was confirmed by cryo-TEM for PVA181-g
7-PHPMA50 (Fig. 1D).
We hypothesise that the graft nature of the macro-initiator, along
with the high-molecular weight stabilising PVA chain, favours the
formation of kinetically-trapped spherical morphologies,47–51 but
further investigation is beyond the scope of this work. Attempts at
dispersing these particles into NaCl (0.1 to 0.01 M) led to macro-
scopic precipitation. Alternatively, PISA was attempted directly in
saline solutions, but no stable particles could be obtained. There-
fore, this formulation, despite containing the desired PVA corona,
could not be used for IRI activity measurements.45 The intolerance
of many monomers used in PISA to saline solutions, specifically
their inability to self-assemble and tendency to precipitate in such
polar media, is a common challenge with PISA formulations and
therefore saline-free buffers are often used.38
It is not possible to change the PVA corona for another
polymer as the PVA is the crucial ice-binding unit. To overcome
the saline instability challenge, we therefore reasoned that
tuning the core-forming block may enable saline-tolerant PISA.
Diacetone acrylamide (DAAm) was investigated as an alternative.
In contrast to HPMA, the DAAm reactions (using the same
polymerisation conditions as above) led to stable nanoparticle
dispersions in both water and in 0.01 M NaCl, with high conver-
sions achieved (497%). It should be noted that we conducted the
screening of PISA in saline, to ensure we selected stable particles,
and to avoid problems due to osmotic pressures upon changing
[NaCl], but we anticipate that aqueous synthesis followed by
addition of saline could also be used. DLS and TEM analysis
(Fig. 2) confirmed the formation of spheres in all cases, agreeing
with our hypothesis (from the HPMA system) that the graft macro-
RAFT agent constrains morphology evolution. (We stress our aim
here was to probe the IRI activity and not to explore the phase
behaviour.) Cryo-TEM imaging on particles also confirmed the
formation of spheres (ESI†).
To evaluate the ice recrystallisation inhibition activity, the
‘splat’ assay was used.13,46 It is important to note that this assay
requires saline to create channels between ice crystals, enabling
recrystallisation to readily occur and hence avoid false positive
results. For this reason the importance of our saline-stabilised
PISA system cannot be understated. Polynucleated ice wafers
were obtained from 10 mL droplets at 80 1C, then annealed at
8 1C for 30 minutes before being photographed and the
average crystal size determined. This method separates nuclea-
tion from growth, and lower values of mean grain size (MGS)
indicates higher activity. The IRI activity of particles from Fig. 2
Fig. 1 (A) Schematic of the synthetic route for PVA181-g
7-PHPMAn nano-
objects at 10% w/w via thermally initiated RAFT dispersion PISA at 60 1C,
using a PVA181macro-CTA. Photographs show precipitation in saline solution
and stable dispersions in water. Characterisation of PVA181-g
7-PHPMA50
nano-objects in aqueous solution; (B) intensity-weighted size distributions,
average Dh and PD values from DLS (error from n = 5). Inset: Autocorrelation
function; representative dry-state (C) and cryo-TEM (D) images (insets show
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are shown in Fig. 3. All the PISA formulations inhibited ice
recrystallisation below 5 mg mL1, and in some cases as low as
0.5 mg mL1, placing them in the highly to very highly active
range of antifreeze-protein mimetics.45 To enable comparison
of multivalent effects (as the particles have different sizes)
Fig. 3C shows the data in terms of total PVA concentration. At
0.5 mg mL1 PVA181-g
7-PDAAm50 showed IRI activity (MGS
40%) but as the core block length increased to PVA181-g
7-
PDAAm300 there was an increase with larger particles inhibiting
growth at 0.1 mg mL1 PVA. This activity, in terms of [PVA] was
greater than the macro-CTA alone, implying a multivalent
enhancement. Previous reports of PVA and antifreeze proteins
grafted to particles or dendrimers24–27 gave no relative enhancement.
We hypothesise that the dense packing of polymer chains in a PISA
particle, compared to those obtained by ‘grafting to’ is crucial to
enhance the IRI activity. It is important to note that the macro-
CTA had lower IRI activity than pure PVA homopolymer.
We used commercial PVA (B80% hydrolysis), which along with
the grafted RAFT agent, breaks up the consecutive hydroxyl group
sequence, which has been shown to be crucial for PVA IRI.13,52,53
The scaling behaviour of IRI’s in different salt solutions may also
affect the magnitude of the results seen here.54 To further
demonstrate the IRI activity, an alternative assay was conducted
in 45 wt% sucrose (‘sucrose sandwich’).26,55 Fig. 3D shows
nucleated ice crystals, which after 2 hours have grown signifi-
cantly (recrystallised) in the absence of particles, Fig. 3E. Fig. 3F
shows that solutions containing 1 mg mL1 of PVA181-g
7-
PDAAm300 display complete inhibition of ice recrystallisation,
demonstrating activity in a range of different formulations.
Finally, ice morphology analysis was conducted. In these
assays the temperature is varied to encourage crystal growth
and to visualise any morphology changes. PVA is known to
bind prismatic faces and hence produces faceting (Fig. 3G)
compared to the solution alone (Fig. 3H), suggesting binding is
occurring.15
Fig. 2 (A) Schematic of the synthetic route employed for the preparation
of PVA181-g
7-PDAAmn (n = 50, 100, 200, 300) nano-objects at 10% w/w via
thermally initiated RAFT dispersion PISA at 60 1C, using a PVA181 macro-
CTA resulting in stable dispersion in both water and in saline; (B) char-
acterisation of PDAAm-core nanoparticles as a function of PDAAm degree
of polymerization by TEM (I), showing the particle size distribution (II) and
also by DLS (III). See ESI† for cryo-TEM analysis. Histograms are from
n 4 50, and DLS is averaged from n = 5.
Fig. 3 Assessment of IRI and ice binding activity. (A) Cryomicrographs
from the ‘splat’ assay of nanoparticles. [PVA] = 0.05 mg mL1; (B) IRI
activity corrected to [PVA]; (C) IRI activity in mass concentration; (D) ice
growth in 45 wt% sucrose t = 0; (E) t = 2 hours, (F) t = 2 hours plus 1 mg mL1
of PVA181-g
7-PDAAm300 nanoparticles; (G) ice shaping of sucrose solution
alone; (H), 1 mg mL1 of PVA181-g























































































Mater. Horiz. This journal is©The Royal Society of Chemistry 2020
Conclusions
In summary, we present a new concept in the design of
biomimetics for controlling ice growth, based upon polymer
nanoparticles with densely grafted coronas. Polymerisation-
induced self-assembly, PISA, was used as a scalable and tuneable
tool to obtain polymer particles from a PVA-graft macroinitiator. By
using DAAm as the core-forming monomer, it was possible to
conduct PISA directly in saline solution, compared to using HPMA
which led tomacroscopic coagulation. Using this system, spherical
nanoparticles ranging from 200–400 nm were obtained and all
were found to be capable of inhibiting ice recrystallisation. The
larger particles were found to be more active than the smaller, and
ice shaping analysis confirmed binding. These results show that it
is possible to develop polymer particles capable of modulating ice
growth processes, which may find application from biomedical to
infrastructure challenges where ice is a problem. It also offers a
practical solution to obtain saline-stable PISA assemblies.
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